Pulse Biosciences (PLSE) Stock Statistics & Valuation Metrics

Pulse Biosciences has a market cap or net worth of $1.07B. The enterprise value is ―.

Pulse Biosciences has 67,767,580 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pulse Biosciences’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -43.92%.

The current PE Ratio of Pulse Biosciences is ―. Pulse Biosciences’s PEG ratio is -4.17.

In the last 12 months, Pulse Biosciences had revenue of 0.00 and earned -53.59M in profits. Earnings per share was -0.92.

In the last 12 months, operating cash flow was -48.51M and capital expenditures -263.00K, giving a free cash flow of -48.77M billion.

Pulse Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Pulse Biosciences upcoming earnings date is Mar 26, 2026, After Close (Confirmed).

Pulse Biosciences as a current ratio of 11.88, with Debt / Equity ratio of 7.89%

In the past 12 months, Pulse Biosciences has paid 0.00 in taxes.

Pulse Biosciences EV to EBITDA ratio is -17.32, with an EV/FCF ratio of -24.89.

Pulse Biosciences has $95.21M in cash and marketable securities with $7.89M in debt, giving a net cash position of $87.32M billion.

Gross margin is 0.90%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Pulse Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―